Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;39(7):e14822.
doi: 10.1111/dme.14822. Epub 2022 Mar 8.

Association of change in haemoglobin A1c with adverse perinatal outcomes in women with pregestational diabetes

Miranda K Kiefer  1 , Matthew M Finneran  2 , Courtney A Ware  1 , Naleef Fareed  3 , Joshua Joseph  4 , Stephen F Thung  1 , Maged M Costantine  1 , Mark B Landon  1 , Steven G Gabbe  1 , Kartik K Venkatesh  1
Affiliations

Association of change in haemoglobin A1c with adverse perinatal outcomes in women with pregestational diabetes

Miranda K Kiefer et al. Diabet Med. 2022 Jul.

Abstract

Aims: To determine whether a net decline in glycosylated haemoglobin (HbA1c ) from early to late pregnancy is associated with lower risk of adverse perinatal outcomes at delivery among women with pregestational diabetes.

Methods: A retrospective analysis from 2012 to 2016 at a tertiary care centre. The exposure was the net change in HbA1c from early (<20 weeks gestation) to late pregnancy (≥20 weeks gestation). Primary outcomes were large for gestational age (LGA) and neonatal hypoglycaemia. The association between outcomes per 6 mmol/mol (0.5%) absolute decrease in HbA1c was evaluated using modified Poisson regression, and adjusted for age, body mass index, White Class, early HbA1c and haemoglobin and gestational age at HbA1c measurement and delivery.

Results: Among 347 women with pregestational diabetes, HbA1c was assessed in early (9 weeks [IQR 7,13]) and late pregnancy (31 weeks [IQR 29,34]). Mean HbA1c decreased from early (59 mmol/mol [7.5%]) to late (47 mmol/mol [6.5%]) pregnancy. Each 6 mmol/mol (0.5%) absolute decrease in HbA1c was associated with a 12% reduced risk of LGA infant (30%, aRR:0.88; 95% CI:0.81,0.95), and a 7% reduced risk of neonatal hypoglycaemia (35%, aRR:0.93; 95% CI:0.87,0.99). Preterm birth (36%, aRR:0.93; 95% CI:0.89,0.98) and neonatal intensive care unit admission (55%, aRR:0.95; 95% CI:0.91,0.98) decreased with a net decline in HbA1c , but not caesarean delivery, pre-eclampsia, shoulder dystocia and respiratory distress syndrome.

Conclusions: Women with pregestational diabetes with a reduction in HbA1c may have fewer infants born LGA or with neonatal hypoglycaemia. Repeated assessment of HbA1c may provide an additional measure of glycaemic control.

Keywords: complications; diabetes; diabetes mellitus; glycosylated haemoglobin; haemoglobin A1c; pregestational diabetes; pregnancy.

PubMed Disclaimer

References

REFERENCES

    1. Coton SJ, Nazareth I, Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012. BMJ Open. 2016;6(1):e009494. doi:10.1136/bmjopen-2015-009494
    1. Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010. Diabetes Care. 2014;37(6):1590-1596. doi:10.2337/dc13-2717
    1. Landon MB, Obstetrics G. Normal and Problem Pregnancies, 8th ed. Elsevier; 2021:874-904.
    1. Davidson AJF, Park AL, Berger H, et al. Risk of severe maternal morbidity or death in relation to elevated hemoglobin A1c preconception, and in early pregnancy: a population-based cohort study. PLoS Medicine. 2020;17(5):e1003104. doi:10.1371/journal.pmed.1003104
    1. Ornoy A, Reece EA, Pavlinkova G, Kappen C, Miller RK. Effect of maternal diabetes on the embryo, fetus, and children: congenital anomalies, genetic and epigenetic changes and developmental outcomes. Birth Defects Res C Embryo Today. 2015;105(1):53-72. doi:10.1002/bdrc.21090

Publication types

Substances